← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2014Last known activity
Dec 20, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 5 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT05498597OfficialPhase 1Dec 20, 2022
- NCT05498597Overall official - principal investigatorPhase 1Dec 20, 2022
- NCT06225336OfficialPhase 1Nov 4, 2022
- NCT05188664OfficialPhase 1/Phase 2May 10, 2022
- NCT05188664Overall official - principal investigatorPhase 1/Phase 2May 10, 2022
- NCT04918810Overall official - principal investigatorPhase 2Jun 30, 2021
- NCT02582697Study chairPhase 3Feb 1, 2014
Details
- Last known activity
- Dec 20, 2022